Professor Redfern AM has been a CI on research grants totalling $30M in the past 5 years and has published over 280 manuscripts and 4 book chapters. She has >15 years of experience developing, testing and implementing scalable strategies to close evidence-practice gaps and improve health outcomes for people with chronic disease. She also has expertise in multidisciplinary and translational research and is an advocate for effective secondary prevention of cardiovascular disease and her research interest is focused on improving clinical practice and reduction of risk factors ultimately in people with a range of chronic diseases.

Professor Redfern has Chaired the Steering Committee for 12 projects (8 clinical trials, 4 cohorts) recruiting >24,000 patients. This inlcudes the QUEL cluster RCT in primary care along with systematic reviews related to improved secondary prevention of heart disease and led the team that won 2022 ACTA Trial of the year for consumer involvement. Professor Redfern’s research program also includes evaluation of peer support strategies, breast cancer survivorship, respiratory disease, data-driven care in primary and outpatient care and digital health.

Professor Redfern leads the SOLVE-CHD program (HOME - solvechd.org.au). The SOLVE-CHD program is supporting capacity building for multidisciplinary research team of researchers and clinicians with allied health, nursing, cardiology, public health, health economics and psychology backgrounds. The goal is to transform post-discharge secondary prevention and reduce the burden of heart disease by decreasing deaths, hospitalisations and costs via a program of work that integrates data, technology, partnerships and capacity building. SOLVE-CHD program includes implementation of a national cardiac rehabilitation excellence and clinician training initiative along with a global transformative initiative supported by the World Heart Federation.